Literature DB >> 31925494

Contrast-enhanced ultrasound applications in liver transplant imaging.

Giuseppe Como1, Luca Montaldo1, Umberto Baccarani2, Dario Lorenzin2, Chiara Zuiani1, Rossano Girometti3.   

Abstract

Contrast-enhanced ultrasound (CEUS) is gaining ever-increasing acceptance in the preoperative and postoperative evaluation of liver-transplanted patients. While indications are still a matter of research, CEUS is used in tertiary centers to supplement ultrasound (US) and Color Doppler US examination, with the potential of providing a comprehensive first-line ultrasound-based diagnosis. Alternatively, CEUS is used as a problem-solving tool when previous cross-sectional or US imaging was inconclusive, especially in assessing hepatocellular carcinoma, parenchymal perfusion abnormalities, the vascular status, and even the biliary tree. This review describes the potential use for CEUS in the setting of orthotopic liver transplantation (OLT).

Entities:  

Keywords:  Complications; Contrast-enhanced ultrasound; Liver; Postoperative; Transplantation; Ultrasound imaging

Mesh:

Substances:

Year:  2021        PMID: 31925494     DOI: 10.1007/s00261-020-02402-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  32 in total

1.  Effects of Needle and Catheter Size on Commercially Available Ultrasound Contrast Agents.

Authors:  John R Eisenbrey; Annemarie Daecher; Michael R Kramer; Flemming Forsberg
Journal:  J Ultrasound Med       Date:  2015-09-18       Impact factor: 2.153

Review 2.  Ultrasound contrast agents: an overview.

Authors:  David Cosgrove
Journal:  Eur J Radiol       Date:  2006-08-30       Impact factor: 3.528

3.  The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

Authors:  Fabio Piscaglia; Luigi Bolondi
Journal:  Ultrasound Med Biol       Date:  2006-09       Impact factor: 2.998

4.  Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.

Authors:  Keiko Korenaga; Masaaki Korenaga; Matakazu Furukawa; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2009-04-23       Impact factor: 7.527

Review 5.  Growing indications for CEUS: The kidney, testis, lymph nodes, thyroid, prostate, and small bowel.

Authors:  V Cantisani; M Bertolotto; H P Weskott; L Romanini; H Grazhdani; M Passamonti; F M Drudi; F Malpassini; A Isidori; F M Meloni; F Calliada; F D'Ambrosio
Journal:  Eur J Radiol       Date:  2015-05-14       Impact factor: 3.528

Review 6.  Imaging of liver transplantation.

Authors:  Rossano Girometti; Martina Pancot; Giuseppe Como; Chiara Zuiani
Journal:  Eur J Radiol       Date:  2017-05-15       Impact factor: 3.528

Review 7.  Post-operative imaging in liver transplantation: state-of-the-art and future perspectives.

Authors:  Rossano Girometti; Giuseppe Como; Massimo Bazzocchi; Chiara Zuiani
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  Contrast-enhanced ultrasound with SonoVue in the evaluation of postoperative complications in pediatric liver transplant recipients.

Authors:  G Bonini; G Pezzotta; C Morzenti; R Agazzi; R Nani
Journal:  J Ultrasound       Date:  2007-06-13

Review 9.  Application of contrast-enhanced ultrasound after liver transplantation: Current status and perspectives.

Authors:  Jie Ren; Tao Wu; Bo-Wen Zheng; Ying-Yi Tan; Rong-Qin Zheng; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 10.  Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery.

Authors:  Vera Paefgen; Dennis Doleschel; Fabian Kiessling
Journal:  Front Pharmacol       Date:  2015-09-15       Impact factor: 5.810

View more
  1 in total

Review 1.  Liver Transplant Imaging prior to and during the COVID-19 Pandemic.

Authors:  Maria Irene Bellini; Daniele Fresilli; Augusto Lauro; Gianluca Mennini; Massimo Rossi; Carlo Catalano; Vito D'Andrea; Vito Cantisani
Journal:  Biomed Res Int       Date:  2022-01-12       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.